Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2006-09-20

FDA Approved: PROZAC — Supplemental Application (Dista Products Company)

View source ↗

Summary

FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company, approving changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prozac (Fluoxetine)

Snippet

SUPPL AP for PROZAC (FLUOXETINE HYDROCHLORIDE)